C82.59

Clinical Causes: Genetic mutations that lead to abnormal B cell growth Previous exposure to certain infections or viruses, such as hepatitis C or HIV Immune system deficiencies or disorders Environmental factors, although specific triggers are not well-established

Key Symptoms: Swollen, painless lymph nodes, often in the neck, armpits, or groin Unexplained weight loss Persistent fatigue and weakness Fever that comes and goes Night sweats Signs of organ involvement, such as abdominal pain if the digestive organs are affected Potential symptoms depending on the extranodal site involved, such as skin or bone symptoms

Diagnosis Path: Diagnosing diffuse follicle center lymphoma involves multiple steps to confirm the presence and extent of the disease. These include: - Physical examination to check for swollen lymph nodes and other signs - Imaging tests such as CT scans, PET scans, or MRI to identify enlarged lymph nodes and affected organs - Biopsy of the affected tissue to examine cells under a microscope and perform immunophenotyping - Laboratory tests, including blood tests to assess overall health and organ function - Bone marrow biopsy in some cases to evaluate if the marrow is involved Accurate staging helps determine the extent of the disease and guides treatment planning.

Treatment Protocols: Treatment strategies for diffuse follicle center lymphoma focus on controlling the disease and improving quality of life. Approaches may include: - Chemotherapy regimens tailored to the individual’s disease stage and health status - Immunotherapy, such as monoclonal antibodies (e.g., rituximab), which target specific cancer cells - Radiation therapy used in localized disease or specific extranodal sites - Targeted therapies or inclusion in clinical trials for newer treatment options - Supportive care to manage symptoms and side effects The choice of treatment depends on various factors, including disease spread, patient age, and overall health.